TABLE 3.
Clinical outcomes between the two groups before and after the PSM analysis.
| Outcome | Before PSM analysis |
After PSM analysis |
||||||
| Staged PCI (n = 154) | Culprit-only PCI (n = 463) | HR (95% CI) | P-value | Staged PCI (n = 80) | Culprit-only PCI (n = 80) | HR (95% CI) | P-value | |
| MACCE | 31 (20.1) | 178 (38.4) | 0.487 (0.332−0.713) | <0.001 | 15 (18.8) | 31 (38.8) | 0.468 (0.252−0.867) | 0.016 |
| All-cause death | 10 (6.5) | 109 (23.5) | 0.264 (0.138−0.504) | <0.001 | 3 (3.8) | 15 (18.8) | 0.185 (0.054−0.636) | 0.007 |
| Cardiac death | 7 (4.5) | 82 (17.7) | 0.247 (0.114−0.534) | <0.001 | 1 (1.3) | 13 (16.3) | 0.075 (0.010−0.577) | 0.013 |
| Recurrent MI | 5 (3.2) | 47 (10.2) | 0.318 (0.126−0.799) | 0.015 | 3 (3.8) | 9 (11.3) | 0.347 (0.094−1.281) | 0.112 |
| Stroke | 6 (3.9) | 20 (4.3) | 0.953 (0.382−2.379) | 0.918 | 4 (5.0) | 2 (2.5) | 2.192 (0.400−12.021) | 0.366 |
| Ischemia-driven revascularization | 16 (10.4) | 57 (12.3) | 0.868 (0.498−1.513) | 0.619 | 9 (11.3) | 13 (16.3) | 0.735 (0.314−1.720) | 0.478 |
PSM, propensity score matching; PCI, percutaneous coronary intervention; HR, hazard ratio; CI, confidence interval; MACCE, major adverse cardiac and cerebrovascular events; MI, myocardial infarction.